SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
基本信息
- 批准号:2459966
- 负责人:
- 金额:$ 17.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-08-16 至 1999-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Atherosclerosis is a complex pathological process that results from an
interplay of genetic and environmental components. Many human beings
develop accelerated atherosclerosis in the absence of known risk factors,
and it has been proposed that some individuals may be genetically
predisposed to develop atherosclerosis as a result of mechanisms Operating
at the level of the arterial wall. Proliferation of smooth muscle cells in
the arterial intima is of key importance in the development and growth of
atherosclerotic lesions. In the proposed studies the hypothesis to be
tested is that genetic susceptibility to atherosclerosis at the artery
wall level includes a differential proliferative response of smooth muscle
cells manifested through a regulatory molecule heparan sulfate
proteoglycan (HSPG). The studies are possible because of the availability
of genetically selected atherosclerosis-susceptible White Carneau (WC) and
-resistant Show Racer (SR) pigeons. Cultured aortic smooth muscle cells
of the WC pigeons demonstrate a greater proliferation capacity than those
of SR. Studies of cell surface HSPG have demonstrated reduced HSPG in WC
compared to SR cells. The HSPG remaining on the surface of WC have low
sulfated octasaccharide and possess a low content of a unique disaccharide
containing iduronic acid 2-O-SO3. When WC HSPG are isolated and added to
WC or SR smooth muscle cells in culture, a low antiproliferative effect is
observed. SR HSPG block the proliferation of SR cells and are less
effective in WC cells. The studies proposed are designed to determine the
mechanisms that result in reduced HSPG on WC cells. Based on preliminary
work, WC cells produce a pool of cell surface HSPG which is transported to
the cell surface but rapidly lost. Possible roles of heparanases and
proteinases in this loss will be explored in cell culture studies to
define a mechanism that may be unique to the WC cells. Through pulse chase
and kinetic modeling, the metabolism and cellular pathways involved in the
fast-turning-over pool of HSPG will be examined. Studies of
oligosaccharides of cell surface HSPG indicated that the reduced
antiproliferative effect of HSPG resulted from the alterations in
oligosaccharide sequences and secondary modifications (e.g., sulfation and
position). Proposed studies will examine the activity of N-deacetylase/N
sulfotransferase, the pivotal enzyme in the production of sulfated
oligosaccharide blocks in HS to determine if structural variations in the
saccharides of WC HS are attributed to differential enzyme activity. The
ultimate goal of the proposal is to determine the role of HSPG in relation
to smooth muscle cell proliferation in atherosclerosis and conditions such
as restenosis following clinical angioplasty.
动脉粥样硬化是一种复杂的病理过程,
遗传和环境因素的相互作用。许多人类
在没有已知危险因素的情况下发生加速的动脉粥样硬化,
有人提出有些人可能在基因上
易患动脉粥样硬化的机制
在动脉壁的水平。平滑肌细胞增殖
动脉内膜在血管的发育和生长中具有关键的重要性,
动脉粥样硬化病变在拟议的研究中,假设
测试的是动脉粥样硬化的遗传易感性
壁水平包括平滑肌的不同增殖反应
细胞通过调节分子硫酸乙酰肝素
蛋白聚糖(HSPG)。这些研究之所以可行,是因为
遗传选择的动脉粥样硬化易感的白色猪(WC)和
- 抗性的Show Racer(SR)鸽子。 培养的主动脉平滑肌细胞
的WC鸽表现出更大的增殖能力比那些
对细胞表面HSPG的研究表明,WC中HSPG减少
与SR细胞相比。残留在WC表面的HSPG含量低,
硫酸化八糖并具有低含量的独特二糖
含有艾杜糖醛酸2-O-SO 3。当WC HSPG被分离并添加到
在培养的WC或SR平滑肌细胞中,
观察 SR HSPG抑制SR细胞增殖,
在WC细胞中有效。拟议的研究旨在确定
导致WC细胞上HSPG减少的机制。根据初步
工作时,WC细胞产生细胞表面HSPG库,其被转运到
细胞表面,但很快失去。乙酰肝素酶的可能作用
在这种损失中的蛋白酶将在细胞培养研究中探索,
定义了WC细胞特有的机制。通过脉冲追踪
和动力学建模,代谢和细胞途径参与的
对HSPG的快速周转池进行了考察。研究
细胞表面HSPG寡糖的减少表明,
HSPG的抗增殖作用可能与HSPG对细胞增殖的抑制作用有关。
寡糖序列和二级修饰(例如,硫酸化和
位置)。拟议的研究将检查N-脱乙酰酶/N
磺基转移酶,在硫酸生产的关键酶
以确定HS中的寡糖块中的结构变化,
WC-HS的差异归因于酶活性的差异。的
该提案的最终目标是确定HSPG在以下方面的作用:
动脉粥样硬化和其他疾病中的平滑肌细胞增殖
临床血管成形术后再狭窄。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Isolation and characterization of a platelet-derived macrophage-binding proteoglycan.
血小板源性巨噬细胞结合蛋白多糖的分离和表征。
- DOI:
- 发表时间:1994
- 期刊:
- 影响因子:0
- 作者:Mas-Oliva,J;Arnold,KS;Wagner,WD;Phillips,DR;Pitas,RE;Innerarity,TL
- 通讯作者:Innerarity,TL
Structural properties and partial protein sequence analysis of the major dermatan sulfate proteoglycan of pigeon aorta.
鸽子主动脉主要硫酸皮肤素蛋白多糖的结构特性和部分蛋白序列分析。
- DOI:10.1016/0021-9150(93)90227-l
- 发表时间:1993
- 期刊:
- 影响因子:5.3
- 作者:Register,TC;Wagner,WD;Robbins,RA;Lively,MO
- 通讯作者:Lively,MO
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM D WAGNER其他文献
WILLIAM D WAGNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM D WAGNER', 18)}}的其他基金
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
- 批准号:
2222502 - 财政年份:1991
- 资助金额:
$ 17.83万 - 项目类别:
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
- 批准号:
3364914 - 财政年份:1991
- 资助金额:
$ 17.83万 - 项目类别:
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
- 批准号:
2222503 - 财政年份:1991
- 资助金额:
$ 17.83万 - 项目类别:
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
- 批准号:
3364913 - 财政年份:1991
- 资助金额:
$ 17.83万 - 项目类别:
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
- 批准号:
3364915 - 财政年份:1991
- 资助金额:
$ 17.83万 - 项目类别:
SMOOTH MUSCLE CELL PROLIFERATION AND ATHEROSCLEROSIS
平滑肌细胞增殖和动脉粥样硬化
- 批准号:
2222504 - 财政年份:1991
- 资助金额:
$ 17.83万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 17.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 17.83万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 17.83万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 17.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 17.83万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 17.83万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 17.83万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 17.83万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
- 批准号:
10974007 - 财政年份:2023
- 资助金额:
$ 17.83万 - 项目类别: